OS02.4 Long-term Outcome of Infants and Young Children with Newly Diagnosed Nodular Desmoplastic Medulloblastoma Treated on “Head Start” III Protocol

Yazar: Dhall, G., Ji, L., Haley, K., Gilles, F., Gardner, S., Sposto, R., Finlay, J. L.
Yayımlandı Neuro Oncol (2017)

P11.02 Long-term Outcome of Infants and Young Children with Newly Diagnosed Non-Nodular/Desmoplastic Medulloblastoma Treated on “Head Start” III Protocol

Yazar: Dhall, G., Ji, L., Haley, K., Gilles, F., Gardner, S., Sposto, R., Finlay, J. L.
Yayımlandı Neuro Oncol (2017)

Activity of irinotecan and temozolomide in the presence of O(6)-methylguanine-DNA methyltransferase inhibition in neuroblastoma pre-clinical models

Yazar: Cai, W, Maldonado, N V, Cui, W, Harutyunyan, N, Ji, L, Sposto, R, Reynolds, C P, Keshelava, N
Baskı/Yayın Bilgisi 2010

Epidermal growth factor and transforming growth factor alpha characteristics of human oral carcinoma cell lines.

Yazar: Prime, S. S., Game, S. M., Matthews, J. B., Stone, A., Donnelly, M. J., Yeudall, W. A., Patel, V., Sposto, R., Silverthorne, A., Scully, C.
Baskı/Yayın Bilgisi 1994

Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell Non-Hodgkin’s Lymphoma: Results of the FAB/LM...

Yazar: Poirel, HA, Cairo, MS, Heerema, NA, Swansbury, J, Aupérin, A, Launay, E, Sanger, WG, Talley, P, Perkins, SL, Raphaël, M, McCarthy, K, Sposto, R, Gerrard, M, Bernheim, A, Patte, C
Baskı/Yayın Bilgisi 2008